Skip to content

13F-HR filed by General Catalyst Group Management, LLC

General Catalyst Group Management, LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 7 holding rows worth $221,740,939.

Accession
0000905148-26-000847
Filed
2026-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A combination report, 7 entries on the cover page, a total value of $221,740,939 stated on the cover page (in dollars after the unit check, H1), rows summing to $221,740,939 with VALUE read as dollars as filed, 13F file number 028-18372. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SAMSARA INC COM CL A79589L106Stock2,000,000$70,900,000dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock1,035,910$42,917,751dollars as filed
GITLAB INC CLASS A COM37637K108Stock921,405$34,580,330dollars as filed
MAPLEBEAR INC COM565394103Stock710,711$31,967,781dollars as filed
ARRIVENT BIOPHARMA INC04272N102COM1,494,786$30,075,094dollars as filed
FRACTYL HEALTH INC35168W103COM4,884,193$10,745,225dollars as filed
FIGMA INC CL A316841105COM14,845$554,758dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000905148-26-000847this filing2026-02-17acceptance time not in the bulk data set